Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Researchers and Healthcare Providers
 Research Grants Program
-Medical and Scientific Advisory Council
 Recent Recommendations
 What is MASAC?
 All MASAC Recommendations
 MASAC Members
 Nursing Working Group
 Social Work Working Group
 Physical Therapy Working Group
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Cell Based Coagulation Animation
 Rare Bleeding and Clotting Disorders Resource Room
 The Partners in Bleeding Disorders Education Program
 NHF/Novo Nordisk HANDI Library

 

 

 
Medical and Scientific Advisory Council
 
Below are treatment recommendations from NHF's Medical and Scientific Advisory Council (MASAC). To learn more about MASAC, click here.


MASAC Document #223
MASAC Recommendations on Liver Biopsy in Individuals with Hemophilia

MASAC Document #222
MASAC Recommendations Regarding Physical Therapy Guidelines in Patients with Bleeding Disorders

MASAC Document #221
MASAC Recommendations on Administration of Vaccines to Individuals with Bleeding Disorders

MASAC Document #220
MASAC Recommendation Regarding Prophylaxis with Bypassing Agents in Patients with Hemophilia and High Titer Inhibitors

MASAC Document #219
MASAC Resolution on Need to Facilitate Dialogue Between HTCs and Payers to Improve Access to Care at HTCs

MASAC Document #218
MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised April 2013)

MASAC Document #216
MASAC Statement Regarding Inhibitor Risk of Factor VIII Concentrates

MASAC Document #214
MASAC Recommendations on the NHF Genotyping Project for Persons with Hemophilia

MASAC Document #213
MASAC Recommendations for Treatment of Chronic HCV Infection in Individuals with Hemophilia and other Rare Bleeding Disorders

MASAC Document #212
MASAC Document Regarding Risks of Gene Therapy Trials for Hemophilia

MASAC Document #211
MASAC Recommendations Regarding Inhibitor Risk and Recombinant Factor VIII Concentrates

MASAC Document #209
MASAC Statement on Biosimilars

MASAC Document #208
MASAC Recommendation on Orphan Drugs

MASAC Document #207
MASAC Recommendations Regarding Non-sterile Alcohol Prep Pads

MASAC Document #206
MASAC Recommendations Regarding Rare Coagulation Factor Disorders

MASAC Document #201
MASAC Recommendations on use of Emergency Medical Identification Devices for Children

MASAC Document #199
MASAC Resolution on Blood Donor Deferral Policy

MASAC Document #197
MASAC Recommendations Regarding Girls and Women with Inherited Bleeding Disorders

MASAC Document #196
MASAC Recommendations Regarding the Treatment of von Willebrand Disease

MASAC Document #194
MASAC Recommendations Regarding Radionuclide Synovectomy

MASAC Document #192
MASAC Guidelines for Perinatal Management of Women with Bleeding Disorders and Carriers of Hemophilia A and B

MASAC Document #191
MASAC Recommendation for Ongoing CDC Surveillance for CJD

MASAC Document #189
MASAC Consensus Statement on Plasma Safety

MASAC Document #188
MASAC Recommendations Regarding Standards of Service for Pharmacy Providers of Clotting Factor Concentrates for Home Use to Patients with Bleeding Disorders

MASAC Document #184
MASAC Concensus Statement Regarding the use of Fresh Frozen Plasma for the Immediate Reversal of the Anticoagualnt Effects and/or Bleeding Complications Associated with Oral Vitamin K Antagonists

MASAC Document #183
MASAC Statement Regarding use of Herbal or Homeopathic Products to Treat Von Willebrand Disease

MASAC Document #180
MASAC Endorsement of the NHLBI Consensus Guidelines on the Diagnosis and Treatment of von Willebrand Disease

MASAC Document #179
MASAC Recommendation Concerning Prophylaxis (Revised November 2007)

MASAC Document #175
Guidelines for Emergency Department Management of Individuals with Hemophilia

MASAC Document #171
MASAC Resolution on National Hemophilia Foundation Sponsorship of Gene Therapy and Novel Technologies Workshops

MASAC Document #169
MASAC Recommendation Regarding the Use of Recombinant Clotting Factor Products with Respect to Pathogen Transmission

MASAC Document #168
MASAC Recommendation Regarding Access to Care for Patients with Bleeding Disorders

MASAC Document #167
MASAC Recommendation Regarding the Use of Bypassing Agents in Patients with Hemophilia A or B and Inhibitors

MASAC Document #166
MASAC Resolution Regarding Preferrred Drug Lists

MASAC Document #162
MASAC Recommendations on Use of Cox-2 Inhibitors in Persons with Bleeding Disorders

MASAC Document #161
MASAC Resolution on Stem Cell Research for Potential Cure of Bleeding Disorders

MASAC Document #160
MASAC Recommendation on the Need for Long-Term Follow-Up of Hemophilic Dogs in Gene Transfer Studies

MASAC Document #159
MASAC Recommendation Regarding Factor Concentrate Prescriptions and Formulary Development and Restrictions

MASAC Document #158
MASAC Recommendations Regarding Exposure to Blood Product Derivatives and Potential Risk of vCJD

MASAC Document #154
MASAC Recommendations Regarding the Use of Antiretroviral Therapy in the Treatment of HIV Infection

MASAC Document #153
MASAC Recommendation Concerning Reimbursement for Recombinant Clotting Factor Concentrates

MASAC Document #152
MASAC Recommendations Regarding the Inclusion of Thrombophilia in NHF Research and Educational Efforts

MASAC Document #150
MASAC Recommendations on the Use of Blood Products During Pregnancy and Testing for Parvovirus B19

MASAC Document #149
MASAC Recommendation on the World Health Organization Essential Drug List

MASAC Document #148
MASAC Resolution on NHF Educational Program for Fellows

MASAC Document #147
Transition Guidelines for People with Bleeding Disorders

MASAC Document #146
MASAC Recommendation Regarding Medicaid Inpatient Clotting Factor Replacement Therapy Reimbursement for Hemophilia

MASAC Document #145
MASAC Recommendation on Funding of the Office of Cellular and Gene Therapies

MASAC Document #144
The Role and Responsibilities of the Principal Investigator In Bleeding Disorder Clinical Trials

MASAC Document #140
MASAC Recommendation on Reporting of Possible West Nile Virus Cases

MASAC Document #139
MASAC Recommendations on the IQPP and QSEAL Programs of the Plasma Protein Therapeutics Association

MASAC Document #137
MASAC Recommendations for Conducting Gene Therapy Clinical Trials in Persons with Bleeding Disorders (Revised November 2002)

MASAC Document #136
MASAC Standard on Disclosing Conflicts of Interest for Individuals Conducting Clinical Research on Bleeding and Clotting Disorders

MASAC Document #132
MASAC Standards and Criteria for the Care of Persons with Congenital Bleeding Disorders (revised 4/2002)

MASAC Document #130
MASAC Recommendation Regarding the Use of Therapeutic Ultrasound to Aid in Blood Resorption

MASAC Document #129
MASAC Resolution Regarding Emergency Supply of Factor Concentrate

MASAC Document #128
MASAC Recommendations for Hepatitis A and B Immunization of Individuals with Bleeding Disorders

MASAC Document #123
MASAC Recommendations Regarding Hepatitis B, Hepatitis C and HIV Postexposure Chemoprophylaxis

MASAC Document #122
MASAC Recommendations Concerning the Use of Antiretroviral Drugs During Pregnancy to Prevent Transmission of HIV to the Infant

MASAC Document #121
MASAC Recommendations for Immunization of HIV-Infected Individuals

MASAC Document #119
MASAC Recommendation Regarding Post HIV-Exposure Chemoprophylaxis

MASAC Document #115
MASAC Recommendations Regarding Central Venous Access Devices Including Ports and Passports

MASAC Document #113
MASAC Recommendations on Improved Access to Emergency Medical Care for Persons with Inherited Bleeding Disorders

MASAC Document #111
MASAC Resolution Concerning the Development of Comprehensive Outcome Measures

MASAC Document #110
MASAC Recommendation Concerning CMV Screening of Blood Products for Use in HIV-Positive Individuals with Hemophilia

MASAC Document #109
MASAC Resolution Concerning Participation in AIDS Clinical Trials by HIV-Infected Persons with Bleeding Disorders

MASAC Document #108
MASAC Recommendation Regarding Treatment of AIDS Wasting

MASAC Document #106
MASAC Recommendation Regarding the Use of Recombinant Clotting Factor Replacement Therapies

MASAC Document #105
MASAC Recommendation Regarding Prevention of Cryptosporidiosis in and the Use of Therapeutic Pools by HIV-Infected Persons

MASAC Document #102
MASAC Recommendation Regarding the Need for Collaborative Effort to Collect Data Regarding Interventions to Prevent Joint Damage Secondary to Hemophilia

MASAC Document #101
MASAC Recommendation Regarding Reimbursement for Treatment of Acquired Hemophilia

MASAC Document #99
MASAC Resolution on Creutzfeldt-Jakob Disease, new variant CJD, and Plasma-Derived Coagulation Products

MASAC Document #94
MASAC Resolution Regarding Consumer Participation in the National Notification System

MASAC Document #93
MASAC Statement on Pregnancy Options for HIV-Discordant Couples

MASAC Document #91
MASAC Recommendation Regarding Risk of Germline Transmission in Gene Therapy Trials for Hemophilia

MASAC Document #90
MASAC Revised Recommendation Regarding Treatment of HCV in HIV Coinfected Individuals with Hemophilia and Other Inherited Bleeding Disorders

MASAC Document #87
MASAC Recommendation on Plasma Transfusion Alternatives

MASAC Document #81
Considerations for Developing Psychosocial Interventions for Women with Bleeding Disorders

MASAC Document #77
MASAC Recommendations Regarding Neonatal Intracranial Hemorrhage and Postpartum Hemorrhage

MASAC Document #73
MASAC Recommendations Regarding Blood Safety Policies

MASAC Document #40
MASAC Resolution on Home Care Delivery Systems

MASAC Document #37
MASAC Recommendation Concerning Parvovirus Transmission by Clotting Factor Concentrates

MASAC Document #32
MASAC Recommendation Concerning Retesting of HIV-Antibody Negative Persons

MASAC Document #31
MASAC Statement on Phase IV Post Licensing Studies

MASAC Document #15
MASAC Resolution on Fetal Tissue Research

View all MASAC Documents by Category >>